Viewing nowCombinationGlipensupreme Plus Tablet (Pitavastatin Calcium, Fenofibrate)
Fenofibrate 145mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 202503282 · Approved 2025.12.15
Treatment of mixed dyslipidemia
Pitavastatin 2mg monotherapy effectively controls LDL cholesterol levels in adult patients with high coronary artery disease. However, this therapy is also used for mixed dyslipidemia, which can increase triglyceride levels and decrease HDL cholesterol levels. This medication primarily helps reduce the risk of cardiovascular diseases by lowering LDL cholesterol. Therefore, Pitavastatin is used to manage lipid levels in patients at high risk for coronary artery disease and contributes to the overall improvement of cardiovascular health.
Take 1 tablet once daily as the recommended dose, with or without food.
This medication contains two ingredients, Pitavastatin Calcium and Fenofibrate, which are used to control blood lipid levels. Caution is advised as muscle-related symptoms such as myalgia, muscle weakness, and muscle cramps may occur during treatment with this drug. Particularly, there is a risk of severe muscle damage known as rhabdomyolysis, which requires immediate consultation with a physician if such symptoms arise. Patients over 65 years old, those with impaired kidney function, uncontrolled hypothyroidism, and individuals with alcohol addiction should undergo blood tests before taking this medication to assess the risk of muscle damage. Using this medication along with other lipid-lowering agents or specific drugs may increase the risk of muscle toxicity; thus, it is important to inform your doctor of any medications you are currently taking. This medication may affect liver function, so patients with liver disease or elevated liver enzymes should have regular check-ups and discontinue if liver function worsens. Additionally, this drug may influence kidney function, requiring special caution in patients with reduced kidney function and regular kidney function tests during treatment. Women who are pregnant, possibly pregnant, or nursing should not take this medication, and it is not administered to children due to safety concerns. Rare side effects such as skin rash, itching, headache, dizziness, dyspepsia, and various mild liver function abnormalities may occur, so immediate consultation with healthcare professionals is advised if any unusual symptoms present. During treatment, regular testing of blood lipid levels as well as liver and kidney function should be conducted, and treatment should be halted if no therapeutic effect is observed. This medication should be temporarily discontinued if there is a planned surgery or significant health condition change. This drug has minimal impact on the ability to drive or operate machinery, but caution is warranted due to the possibility of dizziness. There is no specific antidote for overdose; hence, appropriate treatment should be provided according to the symptoms. Lastly, this medication should be stored out of the reach of children and kept in its original container.
Pharyngitis, upper respiratory tract infection, increased ALT, increased AST, increased GGT, abnormal liver function tests, gastroesophageal reflux disease, nausea, headache, dizziness, increased CPK, hypertension, chronic gastritis, erosive gastritis, decreased hemoglobin, decreased white blood cell count, decreased platelet count, decreased granulocyte count, decreased leukocyte count, increased eosinophils, increased leukocyte count, elevated globulin, positive Coombs test, hypersensitivity, fatigue, stiffness, drowsiness, insomnia, heaviness, paralysis, thromboembolism, interstitial lung disease, gastrointestinal symptoms (abdominal pain, nausea, vomiting, diarrhea, bloating), pancreatitis, thirst, dyspepsia, abdominal fullness, constipation, stomatitis, loss of appetite, glossitis, nausea, gastric discomfort, increased transaminases, cholelithiasis, jaundice, complications of cholelithiasis, increased bilirubin, increased cholinesterase, increased AST, increased ALT, increased γ-GT, increased ALP, increased LDH, decreased aldosterone, increased aldosterone, increased adrenal cortex stimulating hormone, increased cortisol, decreased testosterone, severe skin reaction, skin hypersensitivity, rash, itching, urticaria, alopecia, photosensitivity, muscle disorder, myalgia, myositis, muscle cramps, weakness, renal failure, rhabdomyolysis, myopathy, increased myoglobin, malaise, hematuria, increased urinary frequency, increased BUN, increased serum creatinine, sexual dysfunction, increased homocysteine levels, increased hematuria, palpitations, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, urinary hematuria, increased uric acid levels, elevated serum potassium and phosphorus levels, dysgeusia, colored urine, lethargy, positive antinuclear antibody, hypersensitivity, urticaria, erythema, angioedema, facial edema, arm edema, hypersensitivity, skin tingling, insomnia, sleep disturbances, loss of appetite, increased blood pressure, chest discomfort, weakness, abdominal pain, thirst, constipation, nausea, increased γ-GT, thrombocytopenia, increased serum creatinine, increased BUN
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safe to store at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication for an extended period.
Pink oval film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFenofibrate 145mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium Hydrate 2.205mg · Fenofibrate 160mg
Tablet · Prescription medication · Combination
Ajou Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium Hydrate 2.205mg · Fenofibrate 160mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
CombinationPitavastatin Calcium Hydrate 2.205mg · Fenofibrate 160mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationPitavastatin Calcium Hydrate 2.205mg · Fenofibrate 160mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationFenofibrate 145mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationFenofibrate 145mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
Il Sung IS Co., Ltd.
CombinationFenofibrate 145mg · Pitavastatin Calcium 2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.